Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease

Mesenchymal stem cell (MSC) transplantation, as an alternative strategy to orthotopic liver transplantation, has been evaluated for treating end-stage liver disease. Although the therapeutic mechanism of MSC transplantation remains unclear, accumulating evidence has demonstrated that MSCs can regene...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Mengqin, Hu, Xue, Yao, Lichao, Jiang, Yingan, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066724/
https://www.ncbi.nlm.nih.gov/pubmed/35505419
http://dx.doi.org/10.1186/s13287-022-02858-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066724/
https://www.ncbi.nlm.nih.gov/pubmed/35505419
http://dx.doi.org/10.1186/s13287-022-02858-4

Ejemplares similares